Atlas Trials

Effect of Oral Helicobacter Pylori Infection on the Efficacy of Gastroluminal Helicobacter Pylori Eradication Therapy

Clinical trial NCT05790525 · COMPLETED

Trial details

NCT number
NCT05790525
Sponsor
Xijing Hospital of Digestive Diseases
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori
Start date
2022-11-22
Primary completion
2023-09-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.